Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Director departure
Appointed director
CC transcript
|
|
X4 Pharmaceuticals, Inc (XFOR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/26/2022 |
8-K/A
| Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events Interactive Data |
| 10/18/2019 |
8-K/A
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/17/2019 |
8-K/A
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/13/2019 |
8-K/A
| Financial Statements and Exhibits|
Docs:
|
"8-K/A",
"License Agreement, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, LLC) and Genzyme Corp., a Sanofi company",
"Amendment No. 1 to License Agreement, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) and Genzyme Corporation, a Sanofi company",
"License Agreement, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) and Georgetown University",
"Exclusive License Agreement, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) and Beth Israel Deaconess Medical Center" |
|
|
|